Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)

Market Cap	150.15B -2.4%
Revenue (ttm)	89.83B +38.3%
Net Income	4.33B +232.0%
EPS	2.33 +222.1%
Shares Out	1.85B
PE Ratio	34.89
Forward PE	28.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	354,517
Open	81.42
Previous Close	81.80
Day's Range	80.76 - 81.93
52-Week Range	67.50 - 91.40
Beta	n/a
Analysts	Buy
Price Target	99.36 (+22.27%)
Earnings Date	Nov 4, 2026

About NSE:NIVABUPA

Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness, disease-specific, hospital cash, and maternity insurance; travel insurance plans, including international and studying abroad insurance; and corporate insurance plans comprising group and start up health, group personal accident, and OPD coverage, as well as group health insurance claim process. The company was formerly known as Max Bupa ...

• Industry: Insurance - Life
• Sector: Financials
• Founded: 2008
• Employees: 9,834
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NIVABUPA

Financial Performance

In fiscal year 2026, NSE:NIVABUPA's revenue was 84.43 billion, an increase of 33.38% compared to the previous year's 63.30 billion. Earnings were 3.66 billion, an increase of 80.45%.

Analyst Summary

According to 11 analysts, the average rating for NIVABUPA stock is "Buy." The 12-month stock price target is ₹99.36, which is an increase of 22.27% from the latest price.

Price Target

₹99.36

(22.27% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 31, 2026

Data Sources Report a data error